Trial Profile
A Phase 1 Study of Crizotinib in Combination With Conventional Chemotherapy for Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jan 2024
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary) ; Crizotinib (Primary) ; Crizotinib (Primary) ; Cyclophosphamide; Dexrazoxane; Doxorubicin; Filgrastim; Pegfilgrastim; Topotecan; Vincristine
- Indications Anaplastic large cell lymphoma; Carcinoma; Ewing's sarcoma; Neuroblastoma; Osteosarcoma; Renal cell carcinoma; Sarcoma; Solid tumours
- Focus Adverse reactions
- 22 Feb 2019 Status changed from active, no longer recruiting to completed.
- 04 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Feb 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2018.